News October 7, 2025Jim Wilson's Gemma Bio spins out RareTx to scale gene therapy for ultra-orphan diseases (Philadelphia Business Journal)July 7, 2025Jim Wilson's Gemma Bio enters into its second international gene therapy partnership (Philadelphia Business Journal)July 5, 2025Abu Dhabi to partner with GEMMABio Therapeutics, advance gene therapies for children with spinal muscular atrophy (Aletihad)June 30, 2025'We can't waste money': Dr. James Wilson believes gene therapy needs a new business model (Philadelphia Business Journal)May 27, 2025Geneticist Jim Wilson left UPenn behind, but not his dream of curing rare genetic diseases (The Philadelphia Inquirer)January 27, 2025GEMMABio rakes in $34M raise, a huge boost to the Philly life sciences scene (Technical.ly)December 24, 2024UPenn gene therapy pioneer’s biotech gets $34 million in funding (The Philadelphia Inquirer)October 8, 2024Jim Wilson secures $100M for global approach aimed at reviving gene therapy field (Endpoints News)
